Published in J Virol on September 01, 1995
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92
RNA-mediated neurodegeneration in repeat expansion disorders. Ann Neurol (2010) 2.30
Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol (2003) 1.71
Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. Nucleic Acids Res (2000) 1.53
Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle (2009) 1.39
Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol (2001) 1.20
Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol (2002) 1.17
X-ray structure of Pur-alpha reveals a Whirly-like fold and an unusual nucleic-acid binding surface. Proc Natl Acad Sci U S A (2009) 1.16
Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCVCY in glial cells. Mol Cell Biol (1999) 1.13
Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling. J Biol Chem (2009) 1.11
Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol (2010) 1.10
Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity. Nucleic Acids Res (2001) 1.09
Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J Neuroimmune Pharmacol (2010) 1.08
Modulation of JC virus transcription by C/EBPbeta. Virus Res (2009) 1.05
Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology (2008) 1.05
DNA-binding protein Pur alpha and transcription factor YY1 function as transcription activators of the neuron-specific FE65 gene promoter. Biochem J (1997) 1.04
Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism. J Virol (2006) 1.03
Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol (1999) 1.00
Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol (2003) 0.98
Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. Proc Natl Acad Sci U S A (1999) 0.97
Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen. J Virol (2003) 0.96
Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. J Gen Virol (2010) 0.96
New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy. Clin Dev Immunol (2013) 0.94
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element. Virology (2012) 0.94
DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication. J Gen Virol (2008) 0.94
JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes. J Gen Virol (2011) 0.93
The pur protein family: genetic and structural features in development and disease. J Cell Physiol (2013) 0.87
A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo. Am J Cancer Res (2014) 0.81
Regulation of gonadotropin-releasing hormone-1 gene transcription by members of the purine-rich element-binding protein family. Am J Physiol Endocrinol Metab (2009) 0.80
Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction. J Exp Clin Cancer Res (2014) 0.76
Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells. PLoS One (2016) 0.75
Deep-sequence identification and role in virus replication of a JC virus quasispecies in patients with progressive multifocal leukoencephalopathy. J Virol (2016) 0.75
Human BK Polyomavirus-The Potential for Head and Neck Malignancy and Disease. Cancers (Basel) (2015) 0.75
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Human polyomavirus JC virus genome. J Virol (1984) 5.87
Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (1992) 3.32
JC virus enhancer-promoter active in human brain cells. Science (1984) 2.36
Translational regulation of SV40 early mRNA defines a new viral protein. Cell (1987) 1.70
Regulation of the host range of human papovavirus JCV. Proc Natl Acad Sci U S A (1987) 1.58
Sequence of cDNA comprising the human pur gene and sequence-specific single-stranded-DNA-binding properties of the encoded protein. Mol Cell Biol (1992) 1.53
Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation. J Virol (1989) 1.41
Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem (1989) 1.36
The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell (1986) 1.35
The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res (1993) 1.20
Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Virology (1989) 1.14
A nuclear protein derived from brain cells stimulates transcription of the human neurotropic virus promoter, JCVE, in vitro. J Biol Chem (1990) 1.14
Regulation of JCVL promoter function: evidence that a pentanucleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late promoter. Virology (1991) 1.09
A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus. J Virol (1992) 1.08
Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol Cell Biol (1994) 1.00
A recombinant cDNA derived from human brain encodes a DNA binding protein that stimulates transcription of the human neurotropic virus JCV. J Biol Chem (1991) 1.00
Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology (1993) 0.97
The role of a pentanucleotide repeat sequence, AGGGAAGGGA, in the regulation of JC virus DNA replication. Gene (1994) 0.95
Regulation of a human neurotropic virus promoter, JCVE: identification of a novel activator domain located upstream from the 98 bp enhancer promoter region. Nucleic Acids Res (1990) 0.91
Intraoperative 'no go' donor hepatectomies in living donor liver transplantation. Am J Transplant (2010) 2.33
CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol (2001) 2.30
Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines. Mol Cell Biol (1990) 1.89
Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci (2003) 1.74
Translational regulation of SV40 early mRNA defines a new viral protein. Cell (1987) 1.70
Regulation of the host range of human papovavirus JCV. Proc Natl Acad Sci U S A (1987) 1.58
Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. Nucleic Acids Res (2000) 1.53
Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci U S A (1990) 1.52
Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. J Natl Cancer Inst (1998) 1.48
The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. New Biol (1989) 1.47
Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol (2000) 1.46
The gene encoding the large subunit of human RNA polymerase II. J Biol Chem (1985) 1.42
Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation. J Virol (1989) 1.41
TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J (1992) 1.39
Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol (2004) 1.32
A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res (1998) 1.30
Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology (1995) 1.27
Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J Biol Chem (2000) 1.25
Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene (1999) 1.23
Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology (1996) 1.23
p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome. Gene Ther (2006) 1.22
Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol (2001) 1.20
The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res (1993) 1.20
Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res (2001) 1.20
Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol (1999) 1.20
Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. Arch Pathol Lab Med (2001) 1.15
Interaction of the single-stranded DNA-binding protein Puralpha with the human polyomavirus JC virus early protein T-antigen. J Biol Chem (1998) 1.15
Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci U S A (1999) 1.15
Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem (1998) 1.14
Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Virology (1989) 1.14
A developmentally regulated DNA-binding protein from mouse brain stimulates myelin basic protein gene expression. Mol Cell Biol (1993) 1.14
A nuclear protein derived from brain cells stimulates transcription of the human neurotropic virus promoter, JCVE, in vitro. J Biol Chem (1990) 1.14
Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCVCY in glial cells. Mol Cell Biol (1999) 1.13
Spacing between simian virus 40 early transcriptional control sequences is important for regulation of early RNA synthesis and gene expression. J Virol (1986) 1.13
Evidence for a shift in 5'-termini of early viral RNA during the lytic cycle of JC virus. Virology (1987) 1.12
Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein. J Cell Biochem (1997) 1.12
A 39-kD DNA-binding protein from mouse brain stimulates transcription of myelin basic protein gene in oligodendrocytic cells. J Cell Biol (1995) 1.12
Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha. J Virol (1996) 1.12
Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. Proc Natl Acad Sci U S A (1996) 1.11
Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc Natl Acad Sci U S A (1995) 1.11
Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas. Oncogene (2001) 1.11
Regulation of JCVL promoter function: evidence that a pentanucleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late promoter. Virology (1991) 1.09
A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus. J Virol (1992) 1.08
Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc Natl Acad Sci U S A (1992) 1.08
Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells. Oncogene (2008) 1.07
Identification of a sequence-specific single-stranded DNA binding protein that suppresses transcription of the mouse myelin basic protein gene. J Biol Chem (1995) 1.06
The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J Virol (1994) 1.06
Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses. Oncogene (2006) 1.06
Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci U S A (1996) 1.05
Sequential adrenal infarction without MRI-detectable hemorrhage in primary antiphospholipid-antibody syndrome. AJR Am J Roentgenol (2004) 1.04
Medulloblastomas and the human neurotropic polyomavirus JC virus. Lancet (1999) 1.03
Activation of human B-MYB by cyclins. Proc Natl Acad Sci U S A (1997) 1.03
Isolation and characterization of human actin genes cloned in phage lambda vectors. Gene (1983) 1.02
Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. Virology (2000) 1.01
Review: JC virus infection of lymphocytes--revisited. J Infect Dis (1997) 1.01
The single-stranded DNA binding protein, Pur-alpha, binds HIV-1 TAR RNA and activates HIV-1 transcription. Gene (1998) 1.01
Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus. Oncogene (2006) 1.01
Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: evidence for association of Sp1 and Puralpha in brain. J Cell Physiol (1999) 1.01
Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells. J Virol (1996) 1.00
Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression. Genes Immun (2003) 1.00
A recombinant cDNA derived from human brain encodes a DNA binding protein that stimulates transcription of the human neurotropic virus JCV. J Biol Chem (1991) 1.00
Shut-off of actin biosynthesis in adenovirus serotype-2-infected cells. J Mol Biol (1984) 1.00
Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol Cell Biol (1994) 1.00
Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol (1999) 1.00
Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. Oncogene (1990) 0.99
Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus. Oncogene (2001) 0.99
Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop. Cancer Res (2000) 0.99
Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. J Neurovirol (1999) 0.98
Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription. J Biol Chem (1997) 0.98
TAR-independent replication of human immunodeficiency virus type 1 in glial cells. J Virol (1992) 0.98
Helix-destabilizing properties of the human single-stranded DNA- and RNA-binding protein Puralpha. J Cell Biochem (2001) 0.98
Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol (1994) 0.98
Evaluation of an autoregulatory tetracycline regulated system. Oncogene (1998) 0.97
Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology (1993) 0.97
Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. Proc Natl Acad Sci U S A (1999) 0.97
Transdominant activity of human immunodeficiency virus type 1 Vpr with a mutation at residue R73. J Virol (2000) 0.97
Radiological features of epiploic appendagitis and segmental omental infarction. Clin Radiol (2001) 0.97
Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines. Oncogene (2006) 0.97
Actin mRNAs in HeLa cells. Stabilization after adenovirus infection. J Mol Biol (1984) 0.96
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies. Clin Microbiol Infect (2011) 0.96
Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol (1992) 0.96
Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1. Oncogene (1999) 0.95
Improved intracranial lesion characterization by tissue segmentation based on a 3D feature map. Magn Reson Med (1997) 0.95
Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene (1993) 0.95
A novel role of Rac1 GTPase in JCV T-antigen-mediated beta-catenin stabilization. Oncogene (2007) 0.95
A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. J Biol Chem (1997) 0.95
The human polyomavirus, JCV, and neurological diseases (review). Int J Mol Med (1998) 0.95
The role of a pentanucleotide repeat sequence, AGGGAAGGGA, in the regulation of JC virus DNA replication. Gene (1994) 0.95
GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene (1993) 0.94
Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity. J Gen Virol (1999) 0.94
Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice. Oncogene (2000) 0.93
Human neurotropic JC virus early protein deregulates glial cell cycle pathway and impairs cell differentiation. J Neurosci Res (1999) 0.93
Myelin basic protein gene transcription. Identification of proximal and distal cis-acting regulatory elements. J Biol Chem (1990) 0.93
Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. J Immunol (1995) 0.93
HIV-1 Tat elongates the G1 phase and indirectly promotes HIV-1 gene expression in cells of glial origin. J Biol Chem (1998) 0.93
Integrin involvement in glioblastoma multiforme: possible regulation by NF-kappaB. J Cell Physiol (2000) 0.92
Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1. J Virol (1996) 0.92
Association of Puralpha with RNAs homologous to 7 SL determines its binding ability to the myelin basic protein promoter DNA sequence. J Biol Chem (1998) 0.92